About Simabs
Simabs is a public limited company (NV/SA) based in Diepenbeek, founded in 2019. Its main activity is classified as "Vervaardiging van geneesmiddelen". For the 2025 financial year, Simabs reported a loss of €1.5 million. That makes 5 loss-making financial years in a row for Simabs. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€129,335. It employed an average of 12 full-time equivalents. Equity stands at €1 million, a solvency ratio of 38%. In 2020 it was €835,361. 6 annual accounts are available, covering 2020 to 2025.
- Activities
- Signals
-
Reporting lossesReporting losses € -1.47M
The company reported a loss in the latest financial year.
Negative cashflowNegative cashflow € -1.26MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -1.23MEBITDA is negative: operating activities are loss-making.
Strong equityStrong equity € 1.00MStrong equity provides a buffer against setbacks.
Low riskLow risk 37.6%Good solvency (> 30%) points to long-term financial stability.
Healthy social debtHealthy social debt 9.2%Social debts stay manageable relative to personnel costs.
- Directors
- Chemsciences Middle East Fzc, Eye-Tec Bv Bv, Metatron Holding Nv Nv, +6 more
- Shareholders
- Qbd Growth 37,08%, Pilot Biologix 18,54%, Oak Projects 5,33%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-129K
|
€
-105K
|
€
121K
|
€
-237K
|
|
|
€
-1.23M
|
€
-768K
|
€
-245K
|
€
-572K
|
|
|
€
-1.47M
|
€
-987K
|
€
-453K
|
€
-768K
|
|
|
€
1.00M
|
€
-337K
|
€
650K
|
€
271K
|
|
|
37.59%
|
-30.34%
|
45.56%
|
22.86%
|
|
|
€
1.67M
|
€
1.45M
|
€
776K
|
€
916K
|
|
|
€
971K
|
€
163K
|
€
672K
|
€
342K
|
|
|
12
|
10.80
|
4.80
|
4.80
|
Publications 9
All publications- Statuten (Vertaling, Co?Rdinatie, Overige Wijzigingen, ?) - Kapitaal - Aandelen 13/03/2026
- Statuten (Vertaling, Co?Rdinatie, Overige Wijzigingen, ?) - Kapitaal - Aandelen - Ontslagen - Benoemingen 05/01/2026
- Ontslagen - Benoemingen 05/09/2025
- Diversen 02/09/2024
- Kapitaal - Aandelen - Ontslagen - Benoemingen 20/10/2023
Frequently asked questions
Answers to the most common questions about Simabs, based on official government data and the filed annual accounts.
What is the VAT number of Simabs?
The VAT number of Simabs is BE0732.709.096.
What is the official website of Simabs?
The official website of Simabs is www.simabs.com.
How many employees work at Simabs?
In 2025, Simabs employed 12.00 full-time equivalents (FTE).
When was Simabs established?
Simabs was founded in 20-08-2019.
What is the official address of Simabs?
The official address of Simabs is Agoralaan Abis Diepenbeek 3590.
What is the legal form of Simabs?
The juridical form of Simabs is Public limited company (NV/SA).
What is the annual revenue of Simabs?
The 2025 accounts of Simabs do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Simabs a reliable company?
Simabs is a registered Rechtspersoon with company number 0732.709.096 and can be verified through the official CBE database.
What is the credit limit of Simabs?
The estimated credit limit of Simabs is €39,374.
Is Simabs still active?
Simabs currently has the status "Normal situation" and is active.